A Case of Periocular Capillary Hemangiomas Treated With Propranolol as a Single Therapy
Journal of the Korean Ophthalmological Society
;
: 607-611, 2012.
Artículo
en Coreano
| WPRIM
| ID: wpr-143964
ABSTRACT
PURPOSE:
To report a case of periorbital infantile capillary hemangioma treated with propranolol as a single therapy. CASESUMMARY:
A 3-month-old girl with a growing red-purple mass on the right lower eyelid visited our clinic. The patient was diagnosed with capillary hemagioma by imaging studies. The mass had grown rapidly, and the visual axis was obscured in the follow-up. Oral propranolol therapy was initiated at a starting dose of 0.17 mg/kg at 8-hour intervals. After 2 doses, the propranolol was doubled, and after another 2 doses, the daily dose of 0.67 mg/kg divided into 3 was maintained. Three days after the initiation of the treatment, the color of the hemangioma had changed from red-purple to light purple, and the hemangioma had softened. The hemangioma continued to respond well with no side effects in the following 10 months.CONCLUSIONS:
The authors suggest that oral propranolol treatment as a possibility of an effective and safe option for the vision-threatening periorbital capillary hemangioma as a single therapy.
Texto completo:
Disponible
Índice:
WPRIM (Pacífico Occidental)
Asunto principal:
Propranolol
/
Vértebra Cervical Axis
/
Capilares
/
Estudios de Seguimiento
/
Hemangioma Capilar
/
Párpados
/
Hemangioma
/
Luz
Tipo de estudio:
Estudio observacional
/
Estudio pronóstico
Límite:
Humanos
/
Lactante
Idioma:
Coreano
Revista:
Journal of the Korean Ophthalmological Society
Año:
2012
Tipo del documento:
Artículo
Similares
MEDLINE
...
LILACS
LIS